Abstract
Tolerability and Single Agent Anti-Neoplastic Activity of the CD3xCD123 Bispecific Antibody APVO436 in Patients with Relapsed/Refractory AML or MDS
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have